186 related articles for article (PubMed ID: 31386357)
1. TE1PA as Innovating Chelator for
Navarro AS; Le Bihan T; Le Saëc P; Bris NL; Bailly C; Saï-Maurel C; Bourgeois M; Chérel M; Tripier R; Faivre-Chauvet A
Bioconjug Chem; 2019 Sep; 30(9):2393-2403. PubMed ID: 31386357
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of C-functionalized TE1PA and comparison with its analogues. An example of bioconjugation on 9E7.4 mAb for multiple myeloma
Le Bihan T; Navarro AS; Le Bris N; Le Saëc P; Gouard S; Haddad F; Gestin JF; Chérel M; Faivre-Chauvet A; Tripier R
Org Biomol Chem; 2018 Jun; 16(23):4261-4271. PubMed ID: 29701218
[TBL] [Abstract][Full Text] [Related]
3. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
[TBL] [Abstract][Full Text] [Related]
4. Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.
Cooper MS; Ma MT; Sunassee K; Shaw KP; Williams JD; Paul RL; Donnelly PS; Blower PJ
Bioconjug Chem; 2012 May; 23(5):1029-39. PubMed ID: 22471317
[TBL] [Abstract][Full Text] [Related]
5. Radiolabeling of HTE1PA: A new monopicolinate cyclam derivative for Cu-64 phenotypic imaging. In vitro and in vivo stability studies in mice.
Frindel M; Camus N; Rauscher A; Bourgeois M; Alliot C; Barré L; Gestin JF; Tripier R; Faivre-Chauvet A
Nucl Med Biol; 2014 May; 41 Suppl():e49-57. PubMed ID: 24440584
[TBL] [Abstract][Full Text] [Related]
6. Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
Dearling JL; Voss SD; Dunning P; Snay E; Fahey F; Smith SV; Huston JS; Meares CF; Treves ST; Packard AB
Nucl Med Biol; 2011 Jan; 38(1):29-38. PubMed ID: 21220127
[TBL] [Abstract][Full Text] [Related]
7. Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.
Ghosh SC; Pinkston KL; Robinson H; Harvey BR; Wilganowski N; Gore K; Sevick-Muraca EM; Azhdarinia A
Nucl Med Biol; 2015 Feb; 42(2):177-83. PubMed ID: 25457653
[TBL] [Abstract][Full Text] [Related]
8. New synthesis of phenyl-isothiocyanate C-functionalised cyclams. Bioconjugation and (64)Cu phenotypic PET imaging studies of multiple myeloma with the te2a derivative.
Halime Z; Frindel M; Camus N; Orain PY; Lacombe M; Bernardeau K; Chérel M; Gestin JF; Faivre-Chauvet A; Tripier R
Org Biomol Chem; 2015 Dec; 13(46):11302-14. PubMed ID: 26419637
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography imaging of CD105 expression with a 64Cu-labeled monoclonal antibody: NOTA is superior to DOTA.
Zhang Y; Hong H; Engle JW; Bean J; Yang Y; Leigh BR; Barnhart TE; Cai W
PLoS One; 2011; 6(12):e28005. PubMed ID: 22174762
[TBL] [Abstract][Full Text] [Related]
10. New bifunctional chelator for 64Cu-immuno-positron emission tomography.
Pandya DN; Bhatt N; Dale AV; Kim JY; Lee H; Ha YS; Lee JE; An GI; Yoo J
Bioconjug Chem; 2013 Aug; 24(8):1356-66. PubMed ID: 23883075
[TBL] [Abstract][Full Text] [Related]
11. Design of immunogens: The effect of bifunctional chelator on immunological response to chelated copper.
Zhu X; Miao X; Qin X; Zhu X
J Pharm Biomed Anal; 2019 Sep; 174():263-269. PubMed ID: 31181489
[TBL] [Abstract][Full Text] [Related]
12. 64Cu-labeled 2-(diphenylphosphoryl)ethyldiphenylphosphonium cations as highly selective tumor imaging agents: effects of linkers and chelates on radiotracer biodistribution characteristics.
Yang CT; Kim YS; Wang J; Wang L; Shi J; Li ZB; Chen X; Fan M; Li JJ; Liu S
Bioconjug Chem; 2008 Oct; 19(10):2008-22. PubMed ID: 18763821
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of [
Pougoue Ketchemen J; Njotu FN; Babeker H; Ahenkorah S; Tikum AF; Nwangele E; Henning N; Cleeren F; Fonge H
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2070-2084. PubMed ID: 38376808
[TBL] [Abstract][Full Text] [Related]
14. p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET.
Deri MA; Ponnala S; Kozlowski P; Burton-Pye BP; Cicek HT; Hu C; Lewis JS; Francesconi LC
Bioconjug Chem; 2015 Dec; 26(12):2579-91. PubMed ID: 26550847
[TBL] [Abstract][Full Text] [Related]
15. Promising bifunctional chelators for copper 64-PET imaging: practical (64)Cu radiolabeling and high in vitro and in vivo complex stability.
Wu N; Kang CS; Sin I; Ren S; Liu D; Ruthengael VC; Lewis MR; Chong HS
J Biol Inorg Chem; 2016 Apr; 21(2):177-84. PubMed ID: 26666778
[TBL] [Abstract][Full Text] [Related]
16. MANOTA: a promising bifunctional chelating agent for copper-64 immunoPET.
Moreau M; Poty S; Vrigneaud JM; Walker P; Guillemin M; Raguin O; Oudot A; Bernhard C; Goze C; Boschetti F; Collin B; Brunotte F; Denat F
Dalton Trans; 2017 Oct; 46(42):14659-14668. PubMed ID: 28861553
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of a radiogallium complex-conjugated bisphosphonate as a bone scintigraphy agent.
Ogawa K; Takai K; Kanbara H; Kiwada T; Kitamura Y; Shiba K; Odani A
Nucl Med Biol; 2011 Jul; 38(5):631-6. PubMed ID: 21718937
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bifunctional chelates for (64)Cu antibody imaging.
Ferreira CL; Yapp DT; Crisp S; Sutherland BW; Ng SS; Gleave M; Bensimon C; Jurek P; Kiefer GE
Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2117-26. PubMed ID: 20552190
[TBL] [Abstract][Full Text] [Related]
19. Development of
Woo SK; Jang SJ; Seo MJ; Park JH; Kim BS; Kim EJ; Lee YJ; Lee TS; An GI; Song IH; Seo Y; Kim KI; Kang JH
J Nucl Med; 2019 Jan; 60(1):26-33. PubMed ID: 29777007
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRα) in papillary thyroid cancer using immuno-PET.
Wagner M; Wuest M; Hamann I; Lopez-Campistrous A; McMullen TPW; Wuest F
Nucl Med Biol; 2018 Mar; 58():51-58. PubMed ID: 29367096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
